High-Dose Vitamin C IV

High-dose vitamin C IV therapy delivers ascorbic acid directly into the bloodstream at concentrations 100-500 times higher than oral supplementation can achieve. At these therapeutic levels (typically 25-100 grams per infusion), vitamin C acts not just as an antioxidant but as a powerful pro-oxidant, generating hydrogen peroxide selectively in cancer cells and pathogens while sparing healthy tissue. This dual action, immune enhancement at moderate doses and selective toxicity to cancer cells at high doses, makes vitamin C IV a versatile therapy for both immune support and integrative cancer treatment.

The Nobel Prize-winning chemist Linus Pauling pioneered research on high-dose vitamin C for cancer in the 1970s. While early studies showed mixed results due to differences between IV and oral administration, modern research has validated significant benefits when vitamin C is given intravenously. High-dose vitamin C enhances chemotherapy effectiveness, reduces chemotherapy side effects, improves quality of life in cancer patients, and in some cases, contributes to tumor reduction. Beyond cancer, high-dose IV vitamin C is used for viral infections, chronic fatigue, Lyme disease, and immune system optimization.

Treatment protocols are carefully tailored based on goals and condition. Cancer patients may receive 50-100 gram infusions 2-3 times weekly, while those seeking immune support might use 25-50 gram doses less frequently. The therapy requires laboratory monitoring (G6PD enzyme levels must be checked before treatment as deficiency is a contraindication) and medical supervision. For appropriate candidates, high-dose vitamin C IV offers a safe, well-tolerated adjunctive therapy with both immune-enhancing and potential anti-cancer effects backed by growing clinical evidence.